| Literature DB >> 32917935 |
Sushmitha Vijaya Kumar1, Paul E Abraham2, Gregory B Hurst2, Karuna Chourey2, Amber N Bible1, Robert L Hettich2, Mitchel J Doktycz1,3,4, Jennifer L Morrell-Falvey5,6,7.
Abstract
Membrane organization plays an important role in signaling, transport, and defense. In eukaryotes, the stability, organization, and function of membrane proteins are influenced by certain lipids and sterols, such as cholesterol. Bacteria lack cholesterol, but carotenoids and hopanoids are predicted to play a similar role in modulating membrane properties. We have previously shown that the loss of carotenoids in the plant-associated bacteria Pantoea sp. YR343 results in changes to membrane biophysical properties and leads to physiological changes, including increased sensitivity to reactive oxygen species, reduced indole-3-acetic acid secretion, reduced biofilm and pellicle formation, and reduced plant colonization. Here, using whole cell and membrane proteomics, we show that the deletion of carotenoid production in Pantoea sp. YR343 results in altered membrane protein distribution and abundance. Moreover, we observe significant differences in the protein composition of detergent-resistant membrane fractions from wildtype and mutant cells, consistent with the prediction that carotenoids play a role in organizing membrane microdomains. These data provide new insights into the function of carotenoids in bacterial membrane organization and identify cellular functions that are affected by the loss of carotenoids.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32917935 PMCID: PMC7486946 DOI: 10.1038/s41598-020-71672-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Identification and analysis of the proteins identified in whole cell, membrane pellet, DRM and DSM fractions of Pantoea sp. YR343 and ΔcrtB mutant cells. (a) Histogram representing the number of proteins (averaged from 3 biological replicates) identified from whole cell, membrane fraction (MP), detergent resistant membrane fraction (DRM) and detergent sensitive membrane fractions (DSM) for wild type and the ΔcrtB mutant using proteomics. Statistical significance was calculated by One-way ANOVA. ns non-significant. (b) Venn diagrams comparing the number of identified proteins in common between different samples (whole cell, MP, DRM and DSM). Each ellipse from WT or the mutant represent whole cell, MP, DRM or DSM samples, with the number of common proteins between samples shown in the overlapping regions. The number in the non-overlapping region represents unique proteins for each sample. (c) Comparison of samples using principle component analysis (PCA) based on normalized abundance. The plot illustrates discrete grouping of biological replicates with a major variance observed in PC1 for the DSM samples and in PC2 across the remaining factors.
Figure 2Histogram representing the percentage of proteins with predicted transmembrane helix domains (TMHMM) for each sample. Proteins with predicted transmembrane helices were identified using TMHMM software. The membrane fraction samples contain higher relative amounts of proteins with predicted TMHMM domains, with the DSM fraction having the largest enrichment.
Figure 3Hierarchical clustering of all proteins identified in Pantoea sp. YR343 wildtype and the ΔcrtB mutant. Heatmap of protein counts in Pantoea sp. YR343 wildtype and the ΔcrtB mutant indicate fraction specific abundance of proteins and differential abundance of proteins between wildtype and the ΔcrtB mutant. Higher protein abundance is indicated by red and lower protein abundance is indicated by blue. The heatmap was generated using gplots in Rstudio and scaled by column.
Figure 4Volcano plots illustrating significantly differentially abundant proteins. The − log10 p value (Benjamini–Hochberg corrected) (y-axis) is plotted against the fold change (x-axis) to identify significantly different proteins between sample types. Proteins with significantly increased (green) or decreased (red) abundance are shown for (a) Whole cell fraction; (b) Membrane pellet fraction; (c) DSM fraction; and (d) DRM fraction. The dashed line represents a significance level of p ≤ 0.05 (Student’s t-test).
Figure 5Top orthologous groups for all significant proteins in whole cell, membrane pellet, DRM and DSM samples. The functional classification of statistically significant proteins was organized according to COG assignments. The proteins in each COG category are proportioned based on the fraction in which they are differentially abundant with red indicating whole cell fraction, orange indicating membrane fraction, yellow indicating DRM fraction, and green indicating DSM fraction. The COG category labels are as follows: E-Amino acid transport and metabolism; G-Carbohydrate transport and metabolism; D-Cell cycle control, cell division, chromosome partitioning; N-Cell motility; M-Cell wall/membrane/envelope biogenesis; H-Coenzyme transport and metabolism; V-Defense mechanisms; C-Energy production and conversion; W-Extracellular structures; S-Function unknown R-General function prediction only; P-Inorganic ion transport and metabolism; U-Intracellular trafficking, secretion, and vesicular transport; I-Lipid transport and metabolism; F-Nucleotide transport and metabolism; O-Post-translational modification, protein turnover, and chaperones; L-Replication, recombination and repair; Q-Secondary metabolites biosynthesis, transport, and catabolism; T-Signal transduction mechanisms; K-Transcription; J-Translation, ribosomal structure and biogenesis.
Whole-genome gene ontology (GO) term annotation using Blast2GO software.
| GOID | GO term | Ontology source | No. of genes |
|---|---|---|---|
| GO:0044264 | Cellular polysaccharide metabolic process | GO_BiologicalProcess | 12 |
| GO:0009311 | Oligosaccharide metabolic process | GO_BiologicalProcess | 9 |
| GO:0006629 | Lipid metabolic process | GO_BiologicalProcess | 23 |
| GO:0008610 | Lipid biosynthetic process | GO_BiologicalProcess | 17 |
| GO:0016798 | Hydrolase activity, acting on glycosyl bonds | GO_MolecularFunction | 9 |
| GO:0004553 | Hydrolase activity, hydrolyzing O-glycosyl compounds | GO_MolecularFunction | 9 |
| GO:0015926 | Glucosidase activity | GO_MolecularFunction | 5 |
| GO:0090599 | Alpha-glucosidase activity | GO_MolecularFunction | 3 |
| GO:0016903 | Oxidoreductase activity, acting on the aldehyde or oxo group of donors | GO_MolecularFunction | 9 |
| GO:0019695 | Choline metabolic process | GO_BiologicalProcess | 4 |
| GO:0031455 | Glycine betaine metabolic process | GO_BiologicalProcess | 4 |
| GO:0006578 | Amino-acid betaine biosynthetic process | GO_BiologicalProcess | 4 |
| GO:0019285 | Glycine betaine biosynthetic process from choline | GO_BiologicalProcess | 4 |
| GO:0031456 | Glycine betaine biosynthetic process | GO_BiologicalProcess | 4 |
| GO:0008802 | Betaine-aldehyde dehydrogenase activity | GO_MolecularFunction | 4 |
| GO:0006260 | DNA replication | GO_BiologicalProcess | 4 |
| GO:0050790 | Regulation of catalytic activity | GO_BiologicalProcess | 5 |
| GO:1901698 | Response to nitrogen compound | GO_BiologicalProcess | 3 |
| GO:0031241 | Periplasmic side of cell outer membrane | GO_CellularComponent | 4 |
| GO:0031975 | Envelope | GO_CellularComponent | 21 |
| GO:0030312 | External encapsulating structure | GO_CellularComponent | 16 |
| GO:0030313 | Cell envelope | GO_CellularComponent | 19 |
| GO:0044462 | External encapsulating structure part | GO_CellularComponent | 12 |
| GO:0009279 | Cell outer membrane | GO_CellularComponent | 12 |
| GO:0048038 | Quinone binding | GO_MolecularFunction | 8 |
| GO:0071944 | Cell periphery | GO_CellularComponent | 139 |
| GO:0008104 | Protein localization | GO_BiologicalProcess | 17 |
| GO:1904659 | Glucose transmembrane transport | GO_BiologicalProcess | 4 |
| GO:0030001 | Metal ion transport | GO_BiologicalProcess | 15 |
| GO:0022804 | Active transmembrane transporter activity | GO_MolecularFunction | 33 |
| GO:0055085 | Transmembrane transport | GO_BiologicalProcess | 49 |
| GO:0031224 | Intrinsic component of membrane | GO_CellularComponent | 104 |
| GO:0005886 | Plasma membrane | GO_CellularComponent | 120 |
| GO:0016021 | Integral component of membrane | GO_CellularComponent | 99 |
| GO:0044459 | Plasma membrane part | GO_CellularComponent | 73 |
| GO:0031226 | Intrinsic component of plasma membrane | GO_CellularComponent | 63 |
| GO:0005887 | Integral component of plasma membrane | GO_CellularComponent | 61 |
| GO:0031975 | Envelope | GO_CellularComponent | 31 |
| GO:0098552 | Side of membrane | GO_CellularComponent | 14 |
| GO:0030312 | External encapsulating structure | GO_CellularComponent | 23 |
| GO:0030313 | Cell envelope | GO_CellularComponent | 26 |
| GO:0044462 | External encapsulating structure part | GO_CellularComponent | 19 |
| GO:0009279 | Cell outer membrane | GO_CellularComponent | 19 |
| GO:0031230 | Intrinsic component of cell outer membrane | GO_CellularComponent | 7 |
| GO:0031241 | Periplasmic side of cell outer membrane | GO_CellularComponent | 7 |
| GO:0005829 | Cytosol | GO_CellularComponent | 45 |
| GO:0006090 | Pyruvate metabolic process | GO_BiologicalProcess | 6 |
| GO:0043168 | Anion binding | GO_MolecularFunction | 28 |
| GO:0032553 | Ribonucleotide binding | GO_MolecularFunction | 21 |
| GO:0030554 | Adenyl nucleotide binding | GO_MolecularFunction | 18 |
| GO:0032559 | Adenyl ribonucleotide binding | GO_MolecularFunction | 18 |
| GO:0006082 | Organic acid metabolic process | GO_BiologicalProcess | 28 |
| GO:0044283 | Small molecule biosynthetic process | GO_BiologicalProcess | 22 |
| GO:0016053 | Organic acid biosynthetic process | GO_BiologicalProcess | 16 |
| GO:0043436 | Oxoacid metabolic process | GO_BiologicalProcess | 28 |
| GO:1901566 | Organonitrogen compound biosynthetic process | GO_BiologicalProcess | 25 |
| GO:0019752 | Carboxylic acid metabolic process | GO_BiologicalProcess | 27 |
| GO:0046394 | Carboxylic acid biosynthetic process | GO_BiologicalProcess | 16 |
| GO:1903509 | Liposaccharide metabolic process | GO_BiologicalProcess | 4 |
| GO:0030312 | External encapsulating structure | GO_CellularComponent | 10 |
| GO:0015850 | Organic hydroxy compound transport | GO_BiologicalProcess | 3 |
| GO:0022838 | Substrate-specific channel activity | GO_MolecularFunction | 3 |
| GO:0019725 | Cellular homeostasis | GO_BiologicalProcess | 3 |
| GO:0048878 | Chemical homeostasis | GO_BiologicalProcess | 3 |
| GO:0005783 | Endoplasmic reticulum | GO_CellularComponent | 3 |
| GO:0046873 | Metal ion transmembrane transporter activity | GO_MolecularFunction | 4 |
| GO:0030001 | Metal ion transport | GO_BiologicalProcess | 5 |
| GO:0072511 | Divalent inorganic cation transport | GO_BiologicalProcess | 3 |
| GO:0000041 | Transition metal ion transport | GO_BiologicalProcess | 4 |
| GO:0070838 | Divalent metal ion transport | GO_BiologicalProcess | 3 |
| GO:0045229 | External encapsulating structure organization | GO_BiologicalProcess | 3 |
| GO:0015293 | Symporter activity | GO_MolecularFunction | 3 |
| GO:0022613 | Ribonucleoprotein complex biogenesis | GO_BiologicalProcess | 6 |
| GO:0003723 | RNA binding | GO_MolecularFunction | 8 |
| GO:0042254 | Ribosome biogenesis | GO_BiologicalProcess | 6 |
| GO:0044446 | Intracellular organelle part | GO_CellularComponent | 11 |
| GO:0070925 | Organelle assembly | GO_BiologicalProcess | 4 |
| GO:0071826 | Ribonucleoprotein complex subunit organization | GO_BiologicalProcess | 4 |
| GO:0006518 | Peptide metabolic process | GO_BiologicalProcess | 9 |
| GO:0042273 | Ribosomal large subunit biogenesis | GO_BiologicalProcess | 3 |
| GO:0043232 | Intracellular non-membrane-bounded organelle | GO_CellularComponent | 9 |
| GO:0005840 | Ribosome | GO_CellularComponent | 9 |
| GO:0019843 | rRNA binding | GO_MolecularFunction | 7 |
| GO:0022618 | Ribonucleoprotein complex assembly | GO_BiologicalProcess | 4 |
| GO:0034622 | Cellular protein-containing complex assembly | GO_BiologicalProcess | 4 |
| GO:0043604 | Amide biosynthetic process | GO_BiologicalProcess | 9 |
| GO:0043043 | Peptide biosynthetic process | GO_BiologicalProcess | 9 |
| GO:0044391 | Ribosomal subunit | GO_CellularComponent | 9 |
| GO:0006412 | Translation | GO_BiologicalProcess | 9 |
| GO:0042255 | Ribosome assembly | GO_BiologicalProcess | 4 |
| GO:0044445 | Cytosolic part | GO_CellularComponent | 9 |
| GO:0000027 | Ribosomal large subunit assembly | GO_BiologicalProcess | 3 |
| GO:0015934 | Large ribosomal subunit | GO_CellularComponent | 8 |
| GO:0022626 | Cytosolic ribosome | GO_CellularComponent | 9 |
| GO:0006364 | rRNA processing | GO_BiologicalProcess | 3 |
| GO:0016072 | rRNA metabolic process | GO_BiologicalProcess | 3 |
| GO:0022625 | Cytosolic large ribosomal subunit | GO_CellularComponent | 8 |
Whole gene ontology was performed using Blast2GO with a Blastp E-value hit filter of 1 × 10–5 and annotation cutoff value of 55 and a GO weight of 5. Using ClueGO, observed GO biological process were subjected to the right-sided hypergeometric enrichment test at medium network specificity selection and p value correction was performed using the Holm–Bonferroni step-down method.
Figure 6Clustered heatmap of gene expression in Pantoea sp. YR343 and the ΔcrtB mutant. Hierarchical clustering was performed using absolute transcript counts. Genome wide transcriptional signatures indicated generally lower expression profiles in the ΔcrtB mutant compared to the wildtype. Higher transcript levels are shown in red and lower transcript numbers are shown in blue. The heatmap was generated using gplots in Rstudio and scaled by row.
List of significantly differentially abundant proteins involved in cell wall/membrane/ envelope biogenesis.
Protein list from JGI for each COG category was matched with the proteomics dataset and only proteins that were significantly different in at least one fraction of the wildtype or ΔcrtB mutant are reported. TM/SP- proteins with transmembrane helices or signal peptide. Red: proteins that are significantly less abundant in the ΔcrtB mutant, green: proteins that are significantly more abundant in the ΔcrtB mutant, grey: non-significant proteins and white: proteins that are not detected.
Figure 7Loss of carotenoids affects bacterial cell motility. (a) Swimming motility of wildtype and the ΔcrtB mutant on LB plates with 0.3% agar. Cells were inoculated at the center of the plate from an overnight culture and photographed after 16 h incubation at 28 °C. (b) Cells from motility plates were grown to OD600 of 0.5 and swimming motility videos of 10 biological replicates were collected and processed by ImageJ. (c) Flagella staining with Alexa Fluor 594 carboxylic acid succinimidyl ester was carried out on log-phase cells and imaged using confocal microscopy. (d) Flagellar length measurement (μm) of 30 wildtype and ΔcrtB mutant cells using ImageJ. Statistical significance was detected by t-test p ≤ 0.0001 (****); p ≤ 0.001 (***); p ≤ 0.01 (**) and p ≤ 0.05 (*).
List of significantly differentially abundant proteins involved in cell motility.
Protein list from JGI for each COG category was matched with the proteomics dataset and only proteins that were significantly different in at least in one fraction in the wildtype or ΔcrtB mutant are reported. TM/SP- proteins with transmembrane helices or signal peptide. Red: proteins that are significantly less abundant in the ΔcrtB mutant, green: proteins that are significantly more abundant in the ΔcrtB mutant, grey: non-significant proteins and white: proteins that are not detected.
List of significantly differentially abundant proteins involved in lipid transport and metabolism.
Protein list from JGI for each COG category was matched with the proteomics dataset and only proteins that were significantly different in at least in one fraction in the wildtype or ΔcrtB mutant are reported. TM/SP- proteins with transmembrane helices or signal peptide. Red: proteins that are significantly less abundant in the ΔcrtB mutant, green: proteins that are significantly more abundant in the ΔcrtB mutant, grey: non-significant proteins and white: proteins that are not detected.
List of significantly differentially abundant proteins involved in signal transduction mechanisms.
Protein list from JGI for each COG category was matched with the proteomics dataset and only proteins that were significantly different in at least in one fraction in the wildtype or ΔcrtB mutant are reported. TM/SP- proteins with transmembrane helices or signal peptide. Red: proteins that are significantly less abundant in the ΔcrtB mutant, green: proteins that are significantly more abundant in the ΔcrtB mutant, grey: non-significant proteins and white: proteins that are not detected.